denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Program: Scientific Workshops
Session: Emerging and Long-term Toxicities
Disclosures: Levine: Avectas: Membership on an entity's Board of Directors or advisory committees; Immuneel: Membership on an entity's Board of Directors or advisory committees; Immusoft: Membership on an entity's Board of Directors or advisory committees; In8bio: Membership on an entity's Board of Directors or advisory committees; Ori Biotech: Membership on an entity's Board of Directors or advisory committees; Oxford Biomedica: Membership on an entity's Board of Directors or advisory committees; ThermoFisher Pharma Services: Membership on an entity's Board of Directors or advisory committees; UTC Therapeutics: Membership on an entity's Board of Directors or advisory committees; Tmunity Therapeutics: Current equity holder in publicly-traded company; Capstan Therapeutics: Current equity holder in private company.
See more of: Scientific Workshop on Genomic Toxicities of Gene and Cell Therapies
See more of: Scientific Workshops